| 1 | 1 | | 89R11160 CMO-F |
|---|
| 2 | 2 | | By: Hughes S.B. No. 1976 |
|---|
| 3 | 3 | | |
|---|
| 4 | 4 | | |
|---|
| 5 | 5 | | |
|---|
| 6 | 6 | | |
|---|
| 7 | 7 | | A BILL TO BE ENTITLED |
|---|
| 8 | 8 | | AN ACT |
|---|
| 9 | 9 | | relating to certain testing requirements at certain wastewater |
|---|
| 10 | 10 | | treatment facilities. |
|---|
| 11 | 11 | | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|---|
| 12 | 12 | | SECTION 1. Subchapter B, Chapter 26, Water Code, is amended |
|---|
| 13 | 13 | | by adding Section 26.054 to read as follows: |
|---|
| 14 | 14 | | Sec. 26.054. URINARY METABOLITE TESTING FOR CERTAIN |
|---|
| 15 | 15 | | WASTEWATER TREATMENT FACILITIES. (a) The commission shall conduct |
|---|
| 16 | 16 | | quarterly testing for the urinary metabolites listed in Subsection |
|---|
| 17 | 17 | | (b) of all intakes and outflows of the wastewater treatment |
|---|
| 18 | 18 | | facilities described by Subsection (c). Tests conducted under this |
|---|
| 19 | 19 | | section must be performed by an accredited or certified |
|---|
| 20 | 20 | | environmental testing laboratory. |
|---|
| 21 | 21 | | (b) In accordance with Subsection (a), the commission shall |
|---|
| 22 | 22 | | conduct testing for the following urinary metabolites in the form |
|---|
| 23 | 23 | | of gluconates: |
|---|
| 24 | 24 | | (1) benzophenone; |
|---|
| 25 | 25 | | (2) bisphenol A; |
|---|
| 26 | 26 | | (3) estrone; |
|---|
| 27 | 27 | | (4) ethinyl estradiol; |
|---|
| 28 | 28 | | (5) musk ketone; |
|---|
| 29 | 29 | | (6) pregnanediol; |
|---|
| 30 | 30 | | (7) testosterone; |
|---|
| 31 | 31 | | (8) tonalide (AHTN); |
|---|
| 32 | 32 | | (9) mifepristone; and |
|---|
| 33 | 33 | | (10) any other organic substance required to be tested |
|---|
| 34 | 34 | | for by the commission. |
|---|
| 35 | 35 | | (c) The commission shall conduct the testing required by |
|---|
| 36 | 36 | | this section at: |
|---|
| 37 | 37 | | (1) each wastewater treatment facility located within |
|---|
| 38 | 38 | | 10 miles of a municipality with a population of 250,000 or more; and |
|---|
| 39 | 39 | | (2) at least 10 wastewater treatment facilities |
|---|
| 40 | 40 | | located within 10 miles of a municipality: |
|---|
| 41 | 41 | | (A) with a population of 100,000 or more but less |
|---|
| 42 | 42 | | than 250,000; |
|---|
| 43 | 43 | | (B) with a population of 25,000 or more but less |
|---|
| 44 | 44 | | than 100,000; and |
|---|
| 45 | 45 | | (C) with a population of less than 25,000. |
|---|
| 46 | 46 | | (d) In selecting wastewater treatment facilities for |
|---|
| 47 | 47 | | testing under Subsection (c)(2), the commission shall prioritize |
|---|
| 48 | 48 | | facilities that reasonably represent typical wastewater systems of |
|---|
| 49 | 49 | | municipalities of the population categories in that subsection. |
|---|
| 50 | 50 | | (e) The commission shall maintain detailed records of all |
|---|
| 51 | 51 | | testing conducted under this section and publish the records on the |
|---|
| 52 | 52 | | commission's Internet website. The records must include: |
|---|
| 53 | 53 | | (1) the date on which each sample was collected; |
|---|
| 54 | 54 | | (2) the location from which each sample was collected; |
|---|
| 55 | 55 | | (3) the date on which each sample was tested for the |
|---|
| 56 | 56 | | presence of the urinary metabolites listed in Subsection (b); and |
|---|
| 57 | 57 | | (4) the results of the test for each urinary |
|---|
| 58 | 58 | | metabolite listed in Subsection (b) in parts per trillion. |
|---|
| 59 | 59 | | SECTION 2. This Act takes effect immediately if it receives |
|---|
| 60 | 60 | | a vote of two-thirds of all the members elected to each house, as |
|---|
| 61 | 61 | | provided by Section 39, Article III, Texas Constitution. If this |
|---|
| 62 | 62 | | Act does not receive the vote necessary for immediate effect, this |
|---|
| 63 | 63 | | Act takes effect September 1, 2025. |
|---|